<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Filtenborg Horowitz | Activity</title>
	<link>https://www.catswannabecats.com/members/smashpoison40/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/smashpoison40/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Filtenborg Horowitz.</description>
	<lastBuildDate>Wed, 01 Jul 2026 18:37:05 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4fd3efdb57fc39e681de6fd2ab62e1d2</guid>
				<title>Filtenborg Horowitz posted an update: Two new N-acetyl-ᴅ-glucosamine derivatives, penichryfurans A [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23351/</link>
				<pubDate>Sun, 08 Jun 2025 08:58:14 -0400</pubDate>

									<content:encoded><![CDATA[<p>Two new N-acetyl-ᴅ-glucosamine derivatives, penichryfurans A (1) and B (2), were obtained from the fermentation of an endophytic fungus Penicillium chrysogenum which inhabited the marine medical red alga Grateloupia turuturu. Their structures were established by detailed spectroscopic analysis of 1D and 2D NMR in combination with HRESIMS data. T&hellip;<span class="activity-read-more" id="activity-read-more-23351"><a href="https://www.catswannabecats.com/activity/p/23351/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6685a6bb377a96b6d1117b0d4760a594</guid>
				<title>Filtenborg Horowitz posted an update: Severe asthma commonly affects 5-10% of the asthmatic [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/11808/</link>
				<pubDate>Sun, 01 Jun 2025 08:11:33 -0400</pubDate>

									<content:encoded><![CDATA[<p>Severe asthma commonly affects 5-10% of the asthmatic population and accounts for approximately 50% of the overall asthma costs.</p>
<p> This analysis investigated how severe asthma is diagnosed, treated, and managed by specialists and general practitioners (GPs) in Switzerland.</p>
<p> Two surveys, one each among specialists (N = 44) and GPs (N =&hellip;<span class="activity-read-more" id="activity-read-more-11808"><a href="https://www.catswannabecats.com/activity/p/11808/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b10ab1a28a7537f8b140c9c042763d8d</guid>
				<title>Filtenborg Horowitz posted an update: Wiskott-Aldrich Syndrome, WAS/WAVE, is a rare, X-linked [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/5462/</link>
				<pubDate>Sat, 31 May 2025 14:54:35 -0400</pubDate>

									<content:encoded><![CDATA[<p>Wiskott-Aldrich Syndrome, WAS/WAVE, is a rare, X-linked immune-deficiency disease caused by mutations in the WAS gene, which together with its homolog, N-WASP, regulates actin cytoskeleton remodeling and cell motility. WAS patients suffer from microthrombocytopenia, characterized by a diminished number and size of platelets, though the underlying&hellip;<span class="activity-read-more" id="activity-read-more-5462"><a href="https://www.catswannabecats.com/activity/p/5462/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">580bf4bc2e1d79a16040313b5a3c3562</guid>
				<title>Filtenborg Horowitz became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/5053/</link>
				<pubDate>Sat, 31 May 2025 14:25:27 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>